StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.65−0.23 (-5.93%)

Close on Nov 17, 2026Market cap $525.20MP/E 24.8Yield –

Anbio Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -$6.74M, down 423.9% from the year before.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$6.74M-423.9%
FY2024Dec 31, 2024$2.08M+131.6%
FY2023Dec 31, 2023$898.37K-79.8%
FY2022Dec 31, 2022$4.45M–

More Anbio Biotechnology figures

See a number that looks wrong?